Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 116

1.

Age at diagnosis predicts local recurrence in women treated with breast-conserving surgery and postoperative radiation therapy for ductal carcinoma in situ: a population-based outcomes analysis.

Kong I, Narod SA, Taylor C, Paszat L, Saskin R, Nofech-Moses S, Thiruchelvam D, Hanna W, Pignol JP, Sengupta S, Elavathil L, Jani PA, Done SJ, Metcalfe S, Rakovitch E.

Curr Oncol. 2014 Feb;21(1):e96-e104. doi: 10.3747/co.21.1604.

PMID:
24523627
[PubMed]
Free PMC Article
2.

Can we select individuals with low risk ductal carcinoma in situ (DCIS)? A population-based outcomes analysis.

Rakovitch E, Nofech-Mozes S, Narod SA, Hanna W, Thiruchelvam D, Saskin R, Taylor C, Tuck A, Sengupta S, Elavathil L, Jani PA, Done SJ, Miller N, Youngson B, Kong I, Paszat L.

Breast Cancer Res Treat. 2013 Apr;138(2):581-90. doi: 10.1007/s10549-013-2455-8. Epub 2013 Mar 3.

PMID:
23456231
[PubMed - indexed for MEDLINE]
3.

Impact of boost radiation in the treatment of ductal carcinoma in situ: a population-based analysis.

Rakovitch E, Narod SA, Nofech-Moses S, Hanna W, Thiruchelvam D, Saskin R, Taylor C, Tuck A, Youngson B, Miller N, Done SJ, Sengupta S, Elavathil L, Jani PA, Bonin M, Metcalfe S, Paszat L.

Int J Radiat Oncol Biol Phys. 2013 Jul 1;86(3):491-7. doi: 10.1016/j.ijrobp.2013.02.031.

PMID:
23708085
[PubMed - indexed for MEDLINE]
4.

Significance of multifocality in ductal carcinoma in situ: outcomes of women treated with breast-conserving therapy.

Rakovitch E, Pignol JP, Hanna W, Narod S, Spayne J, Nofech-Mozes S, Chartier C, Paszat L.

J Clin Oncol. 2007 Dec 10;25(35):5591-6. Epub 2007 Nov 5.

PMID:
17984188
[PubMed - indexed for MEDLINE]
Free Article
5.

Long-term Outcomes of Hypofractionation Versus Conventional Radiation Therapy After Breast-Conserving Surgery for Ductal Carcinoma In Situ of the Breast.

Lalani N, Paszat L, Sutradhar R, Thiruchelvam D, Nofech-Mozes S, Hanna W, Slodkowska E, Done SJ, Miller N, Youngson B, Tuck A, Sengupta S, Elavathil L, Chang MC, Jani PA, Bonin M, Rakovitch E.

Int J Radiat Oncol Biol Phys. 2014 Sep 11. pii: S0360-3016(14)03533-0. doi: 10.1016/j.ijrobp.2014.07.026. [Epub ahead of print]

PMID:
25220719
[PubMed - as supplied by publisher]
6.

Breast-conserving treatment with or without radiotherapy in ductal carcinoma In Situ: 15-year recurrence rates and outcome after a recurrence, from the EORTC 10853 randomized phase III trial.

Donker M, Litière S, Werutsky G, Julien JP, Fentiman IS, Agresti R, Rouanet P, de Lara CT, Bartelink H, Duez N, Rutgers EJ, Bijker N.

J Clin Oncol. 2013 Nov 10;31(32):4054-9. doi: 10.1200/JCO.2013.49.5077. Epub 2013 Sep 16.

PMID:
24043739
[PubMed - indexed for MEDLINE]
Free Article
7.

Breast-conserving treatment with or without radiotherapy in ductal carcinoma-in-situ: ten-year results of European Organisation for Research and Treatment of Cancer randomized phase III trial 10853--a study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group.

EORTC Breast Cancer Cooperative Group; EORTC Radiotherapy Group, Bijker N, Meijnen P, Peterse JL, Bogaerts J, Van Hoorebeeck I, Julien JP, Gennaro M, Rouanet P, Avril A, Fentiman IS, Bartelink H, Rutgers EJ.

J Clin Oncol. 2006 Jul 20;24(21):3381-7. Epub 2006 Jun 26.

PMID:
16801628
[PubMed - indexed for MEDLINE]
Free Article
8.

Young age is not associated with increased local recurrence for DCIS treated by breast-conserving surgery and radiation.

Turaka A, Freedman GM, Li T, Anderson PR, Swaby R, Nicolaou N, Goldstein L, Sigurdson ER, Bleicher RJ.

J Surg Oncol. 2009 Jul 1;100(1):25-31. doi: 10.1002/jso.21284.

PMID:
19373863
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Patterns of care analysis among women with ductal carcinoma in situ in North Carolina.

Jackson LC, Camacho F, Levine EA, Anderson RT, Stewart JH 4th.

Am J Surg. 2008 Feb;195(2):164-9.

PMID:
18096124
[PubMed - indexed for MEDLINE]
10.

Local recurrence after breast-conserving surgery: multivariable analysis of risk factors and the impact of young age.

Miles RC, Gullerud RE, Lohse CM, Jakub JW, Degnim AC, Boughey JC.

Ann Surg Oncol. 2012 Apr;19(4):1153-9. doi: 10.1245/s10434-011-2084-6. Epub 2011 Oct 12.

PMID:
21989658
[PubMed - indexed for MEDLINE]
11.

Post-operative radiotherapy for ductal carcinoma in situ of the breast.

Goodwin A, Parker S, Ghersi D, Wilcken N.

Cochrane Database Syst Rev. 2009 Oct 7;(4):CD000563. doi: 10.1002/14651858.CD000563.pub6. Review. Update in: Cochrane Database Syst Rev. 2013;11:CD000563.

PMID:
19821272
[PubMed - indexed for MEDLINE]
12.

Post-operative radiotherapy for ductal carcinoma in situ of the breast.

Goodwin A, Parker S, Ghersi D, Wilcken N.

Cochrane Database Syst Rev. 2009 Jul 8;(3):CD000563. doi: 10.1002/14651858.CD000563.pub5. Review. Update in: Cochrane Database Syst Rev. 2009;(4):CD000563.

PMID:
19588320
[PubMed - indexed for MEDLINE]
13.

259 Patients with DCIS of the breast applying USC/Van Nuys prognostic index: a retrospective review with long term follow up.

Di Saverio S, Catena F, Santini D, Ansaloni L, Fogacci T, Mignani S, Leone A, Gazzotti F, Gagliardi S, De Cataldis A, Taffurelli M.

Breast Cancer Res Treat. 2008 Jun;109(3):405-16. Epub 2007 Aug 9. Review.

PMID:
17687650
[PubMed - indexed for MEDLINE]
14.

p53 overexpression is a predictor of local recurrence after treatment for both in situ and invasive ductal carcinoma of the breast.

de Roos MA, de Bock GH, de Vries J, van der Vegt B, Wesseling J.

J Surg Res. 2007 Jun 1;140(1):109-14. Epub 2007 Feb 7.

PMID:
17291532
[PubMed - indexed for MEDLINE]
15.

Post-operative radiotherapy for ductal carcinoma in situ of the breast.

Goodwin A, Parker S, Ghersi D, Wilcken N.

Cochrane Database Syst Rev. 2009 Jan 21;(1):CD000563. doi: 10.1002/14651858.CD000563.pub4. Review. Update in: Cochrane Database Syst Rev. 2009;(3):CD000563.

PMID:
19160183
[PubMed - indexed for MEDLINE]
16.

Long term follow-up of women with ductal carcinoma in situ treated with breast-conserving surgery: the effect of age.

Van Zee KJ, Liberman L, Samli B, Tran KN, McCormick B, Petrek JA, Rosen PP, Borgen PI.

Cancer. 1999 Nov 1;86(9):1757-67.

PMID:
10547549
[PubMed - indexed for MEDLINE]
17.

Improved outcomes of breast-conserving therapy for patients with ductal carcinoma in situ.

Halasz LM, Sreedhara M, Chen YH, Bellon JR, Punglia RS, Wong JS, Harris JR, Brock JE.

Int J Radiat Oncol Biol Phys. 2012 Mar 15;82(4):e581-6. doi: 10.1016/j.ijrobp.2011.08.015. Epub 2011 Dec 28.

PMID:
22208975
[PubMed - indexed for MEDLINE]
18.

HER2/neu and Ki-67 expression predict non-invasive recurrence following breast-conserving therapy for ductal carcinoma in situ.

Rakovitch E, Nofech-Mozes S, Hanna W, Narod S, Thiruchelvam D, Saskin R, Spayne J, Taylor C, Paszat L.

Br J Cancer. 2012 Mar 13;106(6):1160-5. doi: 10.1038/bjc.2012.41. Epub 2012 Feb 23.

PMID:
22361634
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Breast-conserving therapy for ductal carcinoma in situ of the breast: the French Cancer Centers' experience.

Cutuli B, Cohen-Solal-le Nir C, de Lafontan B, Mignotte H, Fichet V, Fay R, Servent V, Giard S, Charra-Brunaud C, Lemanski C, Auvray H, Jacquot S, Charpentier JC.

Int J Radiat Oncol Biol Phys. 2002 Jul 15;53(4):868-79.

PMID:
12095552
[PubMed - indexed for MEDLINE]
20.

Factors associated with local recurrence and cause-specific survival in patients with ductal carcinoma in situ of the breast treated with breast-conserving therapy or mastectomy.

Vargas C, Kestin L, Go N, Krauss D, Chen P, Goldstein N, Martinez A, Vicini FA.

Int J Radiat Oncol Biol Phys. 2005 Dec 1;63(5):1514-21. Epub 2005 Jul 11.

PMID:
16005576
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk